Los puntos clave no están disponibles para este artículo en este momento.
Estrogen plus progestin does not confer cardiac protection and may increase the risk of CHD among generally healthy postmenopausal women, especially during the first year after the initiation of hormone use. This treatment should not be prescribed for the prevention of cardiovascular disease.
Manson et al. (Thu,) studied this question.